A vitellogenic‐like carboxypeptidase expressed by human macrophages is localized in endoplasmic reticulum and membrane ruffles

Carboxypeptidase, vitellogenic‐like (CPVL) is a serine carboxypeptidase of unknown function that was first characterized in human macrophages. Initial studies suggested that CPVL is largely restricted to the monocytic lineage, although it may also be expressed by cells outside the immune system. Here, we use a new monoclonal antibody to characterize the properties and localization of CPVL in human macrophages to elucidate a possible function for the protease. CPVL is up‐regulated during the maturation of monocytes (MO) to macrophages, although the protein can be seen in both. In primary macrophages, CPVL is glycosylated with high mannose residues and colocalizes with markers for endoplasmic reticulum, while in MO it is more disperse and less clearly associated with endoplasmic reticulum. CPVL is highly expressed in lamellipodia and membrane ruffles, which also concentrate markers of the secretory pathway (MIP‐1α and tumour necrosis factor‐α) and major histocompatibility complex (MHC) class I and II molecules. CPVL can be seen on early latex bead and Candida albicans phagosomes, but it is not retained in the maturing phagosome, unlike MHC class I/II. CPVL has a mixed cytosolic and membrane‐associated localization but is not detectable on the outer plasma membrane. We propose that CPVL may be involved in antigen processing, the secretory pathway and/or in actin remodelling and lamellipodium formation.

[1]  P. Kloetzel,et al.  Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. , 2004, Current opinion in immunology.

[2]  S. Gordon,et al.  Immunophenotyping of macrophages in human pulmonary tuberculosis and sarcoidosis , 2003, International journal of experimental pathology.

[3]  N. Cawley,et al.  Mechanism of Sorting Proopiomelanocortin and Proenkephalin to the Regulated Secretory Pathway of Neuroendocrine Cells , 2002, Annals of the New York Academy of Sciences.

[4]  R. Skidgel,et al.  Carboxypeptidase D is up-regulated in raw 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. , 2001, Molecular pharmacology.

[5]  S. Gordon,et al.  Cloning and characterization of CPVL, a novel serine carboxypeptidase, from human macrophages. , 2001, Genomics.

[6]  C. Watts,et al.  Antigen processing in the endocytic compartment. , 2001, Current opinion in immunology.

[7]  M. Hiraiwa Cathepsin A/protective protein: an unusual lysosomal multifunctional protein , 1999, Cellular and Molecular Life Sciences CMLS.

[8]  R. Skidgel,et al.  Cellular carboxypeptidases , 1998, Immunological reviews.

[9]  M. Rehli,et al.  Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B virus-binding protein. , 1997, Life sciences.

[10]  L. Pannell,et al.  Carboxypeptidase E Is a Regulated Secretory Pathway Sorting Receptor: Genetic Obliteration Leads to Endocrine Disorders in Cpefat Mice , 1997, Cell.

[11]  L. Fricker,et al.  Processing of Procarboxypeptidase E into Carboxypeptidase E Occurs in Secretory Vesicles , 1995, Journal of neurochemistry.

[12]  P. Cresswell,et al.  Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Tonegawa,et al.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective , 1993, Cell.

[14]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[15]  J. Lippincott-Schwartz,et al.  Degradation of proteins within the endoplasmic reticulum. , 1991, Current opinion in cell biology.

[16]  N. Galjart,et al.  Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases , 1988, Cell.

[17]  H. Galjaard,et al.  Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. G. Erdös,et al.  Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. , 1978, The Journal of biological chemistry.

[19]  R. Tampé,et al.  Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells , 2005, Nature Immunology.

[20]  John Q. Davies,et al.  Isolation and culture of human macrophages. , 2005, Methods in molecular biology.

[21]  S. Gordon,et al.  The Macrophage as Therapeutic Target , 2003, Handbook of Experimental Pharmacology.

[22]  B. V. Jones,et al.  Production of stable bovine-murine interspecies hybrids. , 1995, Methods in molecular biology.